Literature DB >> 8262371

Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies.

M Tilley1, M T Eggleston, S J Upton.   

Abstract

Oral immunization of suckling mice with Cryptosporidium parvum results in a humoral response to a limited set of antigens. Six-day-old BALB/c mice were each inoculated orally with 1 x 10(6) viable oocysts and subsequently administered oral inoculations of 2 x 10(6) viable oocysts at 30 and 60 days following the primary infection. After 45 days, mice were boosted with 1 x 10(6) oocysts orally, plus soluble extracts equivalent to 2 x 10(6) and 1 x 10(6) oocysts given intravenously and intraperitoneally, respectively. Four days later, splenic lymphocytes were fused to Ag8 myeloma cells. Using this method, we have been able to select for monoclonal antibodies that predominantly recognize sporozoite surface and apical complex antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262371     DOI: 10.1111/j.1574-6968.1993.tb06520.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  4 in total

1.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.

Authors:  R C Langer; M W Riggs
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 3.  Cryptosporidium pathogenicity and virulence.

Authors:  Maha Bouzid; Paul R Hunter; Rachel M Chalmers; Kevin M Tyler
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

4.  Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.

Authors:  D A Schaefer; B A Auerbach-Dixon; M W Riggs
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.